Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway
Li, Jun-Fei; Zheng, Xiao-Rong; Zhang, Hong-Yan; Shen, Chang-Ming; Shen, Guo-xin; Jiang, Jian-Wei
刊名EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
2022-10-15
卷号2022
ISSN号1741-427X
DOI10.1155/2022/1911311
通讯作者Jiang, Jian-Wei(jiangjw@zjcc.org.cn)
英文摘要Purpose. This study focused on determining the anticancer effect of paeoniflorin and geniposide mixture (PFGS) combined with sorafenib (Sor) in hepatocellular carcinoma (HCC) and, in particular, whether PFGS increases the antitumor effect of Sor by modulating the NF-kappa B/HIF-2 alpha/SerpinB3 pathway. Methods. The H22 hepatoma tumor-bearing mouse model was treated with PFGS, Sor, and a combination of the two drugs for 12 days. The effects of PFGS combined with Sor on tumor growth and apoptosis and the expression of NF-kappa B, HIF-2 alpha, and SerpinB3 in tumor tissue were assessed. In addition, Sor-resistant hepatoma cells were treated with PFGS, Sor, and the combination of the two drugs in vitro. The effects of PFGS combined with Sor on cell proliferation and invasion and the protein expression of NF-kappa B p65, HIF-2 alpha, and SerpinB3 were investigated. Results. PFGS combined with Sor treatment synergistically inhibited tumor growth in HCC tumor-bearing mice. Immunostaining showed that PFGS combined with Sor treatment significantly decreased the expression of Ki-67 and obviously induced apoptosis in the tumor compared with a single treatment. Similarly, PFGS combined with Sor treatment significantly downregulated the expression of NF-kappa B, HIF-2 alpha, and SerpinB3 in the tumor compared with a single treatment. Additionally, PFGS combined with Sor markedly inhibited cell proliferation and invasion and activation of the NF-kappa B/HIF-2 alpha/SerpinB3 pathway in Sor-resistant hepatoma cells compared with a single treatment. Conclusion. Our study demonstrated that PFGS synergistically increased the antiliver cancer effects of Sor by lowering activation of the NF-kappa B/HIF-2 alpha/SerpinB3 pathway. These findings provided a scientific foundation for clinical studies using PFGS and Sor to treat liver cancer.
资助项目Zhejiang Province Medical Health Science and Technology Project[2020KY074] ; Zhejiang provincial Science and Technology Plan of Traditional Chinese Medicine[2022ZA025]
WOS关键词NF-KAPPA-B ; HEPATOCELLULAR-CARCINOMA ; EXPRESSION ; RESISTANCE ; SERPINB3 ; METASTASIS ; SYNERGIZES ; AUTOPHAGY ; EFFICACY
WOS研究方向Integrative & Complementary Medicine
语种英语
出版者HINDAWI LTD
WOS记录号WOS:000876508200001
资助机构Zhejiang Province Medical Health Science and Technology Project ; Zhejiang provincial Science and Technology Plan of Traditional Chinese Medicine
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/130041]  
专题中国科学院合肥物质科学研究院
通讯作者Jiang, Jian-Wei
作者单位Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC, Chinese Acad Sci,Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Li, Jun-Fei,Zheng, Xiao-Rong,Zhang, Hong-Yan,et al. Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2022,2022.
APA Li, Jun-Fei,Zheng, Xiao-Rong,Zhang, Hong-Yan,Shen, Chang-Ming,Shen, Guo-xin,&Jiang, Jian-Wei.(2022).Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2022.
MLA Li, Jun-Fei,et al."Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway".EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2022(2022).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace